MedTrace Logo

Food Effect and CYP1A2 Induction Study in Healthy Subjects

NCT02168205 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2018-11-15

No results posted yet for this study

Summary

This study will evaluate the effect of food and smoking on healthy older subjects taking pomalidomide.

Conditions

  • Healthy Volunteers

Interventions

DRUG

Pomalidomide

Capsules

OTHER

Caffeine

Capsules

OTHER

Tobacco

Cigarettes

Sponsors & Collaborators

  • Celgene

    lead INDUSTRY

Principal Investigators

  • Edward O'Mara, MD · Celgene

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-30
Primary Completion
2014-09-19
Completion
2014-09-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02168205 on ClinicalTrials.gov